EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Biological Evaluation of Oxindole Sulfonamide Derivatives as Bruton's Tyrosine Kinase Inhibitors**

Chandra Prakash Koraboina, Venkatanarayana Chowdary Maddipati, Narendran Annadurai, Soňa Gurská, Petr Džubák, Marián Hajdúch, Viswanath Das iD, Rambabu Gundla

ChemMedChem · 02.01.2024 · 19 (1)

DOI: 10.1002/cmdc.202300511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 22.11.2023. Verfasst von Chandra Prakash Koraboina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Science, GITAM (Deemed to be University), Hyderabad, Telangana, 502 329, India. Hauptthemen laut MEDLINE: Tyrosine Kinase Inhibitors, Burkitt Lymphoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology, India, CZ-OPENSCREEN, EATRIS-CZ.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bruton's tyrosine kinase (BTK) is a promising molecular target for several human B‐cell‐related autoimmune disorders, inflammation, and haematological malignancies. The pathogenic alterations in various cancer tissues depend on mutant BTK for cell proliferation and survival, and BTK is also overexpressed in a range of hematopoietic cells. Due to this, BTK is emerging as a potential drug target to treat various human diseases, and several reversible and irreversible inhibitors have been developed and are being developed. As a result, BTK inhibition, clinically validated as an anticancer treatment, is finding great interest in B‐cell malignancies and solid tumours. This study focuses on the design and synthesis of new oxindole sulfonamide derivatives as promising inhibitors of BTK with negligible off‐target effects. The most cytotoxic compounds with greater basicity were PID‐4 (2.29±0.52 μM), PID‐6 (9.37±2.47 μM), and PID‐19 (2.64±0.88 μM). These compounds caused a selective inhibition of Burkitt's lymphoma RAMOS cells without significant cytotoxicity in non‐BTK cancerous and non‐cancerous cell lines. Further, PID‐4 showed promising activity in inhibiting BTK and downstream signalling cascades. As a potent inhibitor of Burkitt's lymphoma cells, PID‐4 is a promising lead for developing novel chemotherapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tyrosine Kinase InhibitorsBurkitt LymphomaHumansProtein Kinase InhibitorsAgammaglobulinaemia Tyrosine KinaseSulfonamides

Stichwörter der Autor:innen

AntiproliferationB-cell malignanciesBruton's tyrosine kinaseCytotoxicityKnoevenagel condensationOxindole sulfonamide

Substanzen

Tyrosine Kinase InhibitorsProtein Kinase InhibitorsAgammaglobulinaemia Tyrosine KinaseSulfonamides

Autor:innen und Institutionen

  • Department of Chemistry, School of Science, GITAM (Deemed to be University), Hyderabad, Telangana, 502 329, India.
  • Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Hněvotínská 1333/5, 77900, Olomouc, Czech Republic.
  • Czech Advanced Technologies and Research Institute (CATRIN), Institute of Molecular and Translational Medicine, Palacký University Olomouc, Křížkovského 511/8, 77900, Olomouc, Czech Republic.

ORCID-Profile: Viswanath Das

Förderung

  • Department of Science and Technology, India
  • CZ-OPENSCREEN
  • EATRIS-CZ
  • National Institute for Cancer Research
  • National Institute for Neurological Research
  • Ministry of Education, Youth and Sports of the Czech Republic (MEYS)

Zitieren

APA

Koraboina, C. P., Maddipati, V. C., Annadurai, N., Gurská, S., Džubák, P., Hajdúch, M., Das, V., & Gundla, R. (2024). Synthesis and Biological Evaluation of Oxindole Sulfonamide Derivatives as Bruton's Tyrosine Kinase Inhibitors**. ChemMedChem, 19(1). https://doi.org/10.1002/cmdc.202300511

Vancouver

Koraboina CP, Maddipati VC, Annadurai N, Gurská S, Džubák P, Hajdúch M, et al. Synthesis and Biological Evaluation of Oxindole Sulfonamide Derivatives as Bruton's Tyrosine Kinase Inhibitors**. ChemMedChem. 2024;19(1). doi:10.1002/cmdc.202300511

BibTeX
@article{Koraboina2024,
  author = {Koraboina, Chandra Prakash and Maddipati, Venkatanarayana Chowdary and Annadurai, Narendran and Gurská, Soňa and Džubák, Petr and Hajdúch, Marián and Das, Viswanath and Gundla, Rambabu},
  title = {Synthesis and Biological Evaluation of Oxindole Sulfonamide Derivatives as Bruton's Tyrosine Kinase Inhibitors**},
  journal = {ChemMedChem},
  year = {2024},
  volume = {19},
  number = {1},
  doi = {10.1002/cmdc.202300511}
}
Kostenlos starten →